Hospital
Henry Ford Health Macomb Oakland Hospital
Henry Ford Health Macomb Oakland Hospital was paid $59.25M by Medicaid between Jan 2018 and Dec 2024, across 362 billing codes. Its largest line is 99285, emergency room visit (most serious) — 30% of everything it billed.
33Billing provider infoHENRY FORD HEALTH MACOMB OAKLAND HOSPITAL
WARREN, MI 48093
WARREN, MI 48093
33aNPI1124099858assigned 01/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$59.25M
24GClaims1,583,645
24DCodes billed362
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#20 of 86
Median peer was paid$21.55M
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 224,669 | $8.03M | |
| 2019 | 237,728 | $8.36M | |
| 2020 | 215,101 | $7.54M | |
| 2021 | 236,822 | $9.35M | |
| 2022 | 255,260 | $9.82M | |
| 2023 | 242,585 | $9.39M | |
| 2024incomplete | 171,480 | $6.76M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 30% | 47,660 | 44,743 | $17.93M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 46,873 | 44,738 | $7.89M |
| G0378 | Hospital observation service, per hour | 9.8% | 18,584 | 15,509 | $5.82M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.8% | 39,347 | 37,897 | $5.20M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.8% | 38,584 | 36,106 | $2.82M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.0% | 38,500 | 34,555 | $1.79M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.7% | 2,056 | 2,002 | $980K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 23,556 | 21,937 | $908K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 9,467 | 9,289 | $885K |
| 80061 | Lipid panel | 1.4% | 2,527 | 2,426 | $839K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 7,968 | 7,749 | $767K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 7,120 | 6,957 | $641K |
350 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 8,374 | $632K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 22,525 | $616K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 9,877 | $605K |
| 82947 | <1% | 15,273 | $541K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 21,280 | $527K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 1,087 | $469K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 18,835 | $442K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 5,922 | $408K |
| 71045 | Radiologic examination, chest; single view | <1% | 12,911 | $367K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17,254 | $350K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,830 | $324K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,896 | $309K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 844 | $297K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 5,833 | $288K |
| 59025 | Fetal non-stress test | <1% | 3,180 | $287K |
| 93975 | <1% | 3,513 | $268K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 16,038 | $249K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 724 | $223K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,991 | $215K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 385 | $193K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 992 | $187K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 13,247 | $183K |
| 76801 | <1% | 4,013 | $171K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 4,123 | $169K |
| 95811 | <1% | 338 | $168K | |
| 76830 | Ultrasound, transvaginal | <1% | 3,732 | $165K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 2,978 | $154K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,268 | $140K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,754 | $138K |
| 97162 | <1% | 2,613 | $136K | |
| 58558 | <1% | 109 | $135K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,220 | $135K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,818 | $131K |
| 83735 | <1% | 50,410 | $130K | |
| A9270 | Non-covered item or service | <1% | 64,569 | $128K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 280 | $117K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,456 | $116K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 238 | $107K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 911 | $106K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,600 | $91K |
| 72141 | <1% | 735 | $89K | |
| 93971 | <1% | 2,347 | $88K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,804 | $83K |
| 93458 | <1% | 53 | $78K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,180 | $77K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,004 | $66K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 5,005 | $65K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,258 | $61K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,080 | $58K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 732 | $57K |
| 93970 | <1% | 852 | $56K | |
| 70491 | <1% | 690 | $53K | |
| 82550 | <1% | 8,377 | $53K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 7,898 | $51K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 20,005 | $46K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 7,895 | $44K |
| 76642 | <1% | 1,703 | $43K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 51 | $42K |
| 76770 | <1% | 1,017 | $41K | |
| 10060 | <1% | 573 | $36K | |
| 70486 | <1% | 1,772 | $34K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 4,641 | $34K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,093 | $34K |
| 77065 | Tomosynthesis, mammo | <1% | 766 | $34K |
| 84484 | <1% | 19,969 | $33K | |
| 83690 | <1% | 21,397 | $33K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 477 | $33K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 53 | $30K |
| 72131 | <1% | 1,273 | $30K | |
| 72110 | <1% | 1,126 | $28K | |
| 93017 | <1% | 1,103 | $28K | |
| 83605 | <1% | 7,638 | $28K | |
| 20610 | <1% | 122 | $27K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 487 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 36,806 | $26K |
| 90715 | <1% | 3,483 | $25K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,190 | $25K |
| 73564 | <1% | 3,802 | $23K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 165 | $23K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 225 | $23K |
| 97163 | <1% | 380 | $22K | |
| C8930 | Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision | <1% | 121 | $20K |
| 90651 | <1% | 179 | $19K | |
| 70496 | <1% | 592 | $18K | |
| 97166 | <1% | 439 | $18K | |
| 97161 | <1% | 341 | $18K | |
| 50590 | <1% | 15 | $17K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,741 | $17K |
| 86900 | <1% | 9,916 | $17K | |
| 71271 | <1% | 264 | $16K | |
| 77066 | Tomosynthesis, mammo | <1% | 253 | $15K |
| 70487 | <1% | 245 | $15K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,130 | $14K |
| 90686 | <1% | 932 | $14K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 853 | $12K |
| 97035 | <1% | 2,129 | $12K | |
| 90732 | <1% | 112 | $12K | |
| 73030 | <1% | 2,832 | $12K | |
| 97116 | <1% | 2,018 | $12K | |
| 97014 | <1% | 1,405 | $12K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 61,701 | $11K |
| 73130 | <1% | 3,565 | $11K | |
| 19083 | <1% | 13 | $11K | |
| 72100 | <1% | 750 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,986 | $10K |
| 71250 | <1% | 213 | $10K | |
| 76536 | <1% | 194 | $9K | |
| 73630 | <1% | 4,219 | $9K | |
| 99385 | <1% | 289 | $8K | |
| 90688 | <1% | 502 | $8K | |
| 90674 | <1% | 285 | $8K | |
| 73610 | <1% | 3,161 | $7K | |
| 70498 | <1% | 625 | $7K | |
| 70355 | <1% | 1,410 | $6K | |
| 73502 | <1% | 1,144 | $6K | |
| 74018 | <1% | 691 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,917 | $6K |
| 73110 | <1% | 1,825 | $6K | |
| 70470 | <1% | 99 | $6K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 459 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 84,782 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 24,637 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 10,082 | $5K |
| 11043 | <1% | 15 | $5K | |
| 29515 | <1% | 93 | $4K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 215 | $4K |
| 93798 | <1% | 82 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,117 | $4K |
| 99406 | <1% | 290 | $4K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 182 | $4K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 70 | $4K |
| 96160 | <1% | 408 | $4K | |
| 77336 | <1% | 60 | $4K | |
| 82728 | <1% | 804 | $4K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 157 | $4K |
| 97022 | <1% | 516 | $3K | |
| 82565 | <1% | 3,066 | $3K | |
| 95819 | <1% | 64 | $3K | |
| 72128 | <1% | 125 | $2K | |
| 94726 | <1% | 53 | $2K | |
| 74178 | <1% | 15 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 177 | $2K |
| 82805 | <1% | 981 | $2K | |
| 74022 | <1% | 4,042 | $2K | |
| 81025 | <1% | 39,049 | $2K | |
| 94010 | <1% | 78 | $2K | |
| 83880 | <1% | 3,505 | $2K | |
| 85730 | <1% | 19,492 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 12,358 | $2K |
| 90656 | <1% | 12 | $2K | |
| 72170 | <1% | 1,655 | $2K | |
| 90661 | <1% | 110 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 8,073 | $2K |
| 12001 | <1% | 1,092 | $2K | |
| 93351 | <1% | 12 | $2K | |
| 74183 | <1% | 12 | $2K | |
| 73590 | <1% | 1,035 | $2K | |
| 88304 | <1% | 1,399 | $2K | |
| 77080 | <1% | 24 | $1K | |
| 85610 | <1% | 21,699 | $1K | |
| 73080 | <1% | 811 | $1K | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 187 | $1K |
| 84702 | <1% | 7,259 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 140 | $1K |
| 93880 | <1% | 19 | $1K | |
| 84520 | <1% | 2,601 | $1K | |
| 88342 | <1% | 387 | $1K | |
| 90654 | <1% | 49 | $950.89 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,466 | $943.11 |
| 86850 | <1% | 9,355 | $896.74 | |
| 88300 | <1% | 1,306 | $873.69 | |
| 12002 | <1% | 377 | $835.00 | |
| 99495 | <1% | 12 | $819.54 | |
| 82247 | <1% | 1,214 | $775.11 | |
| 90658 | <1% | 66 | $755.00 | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 24 | $750.27 |
| 82248 | <1% | 1,506 | $745.02 | |
| 87428 | <1% | 27 | $737.94 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 563 | $709.14 |
| 73090 | <1% | 709 | $674.17 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 137 | $664.49 |
| 80051 | <1% | 1,780 | $655.93 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 7,411 | $652.22 |
| 83037 | <1% | 156 | $631.50 | |
| 73702 | <1% | 13 | $608.81 | |
| 81000 | <1% | 349 | $592.50 | |
| 72050 | <1% | 12 | $569.99 | |
| 98927 | <1% | 60 | $540.98 | |
| 99386 | <1% | 14 | $504.00 | |
| 81001 | <1% | 39,577 | $493.96 | |
| 96367 | <1% | 25 | $489.45 | |
| 74019 | <1% | 68 | $479.26 | |
| 0011A | <1% | 13 | $466.33 | |
| 73140 | <1% | 96 | $451.93 | |
| J2359 | Injection, olanzapine, 0.5 mg | <1% | 86 | $445.58 |
| 71101 | <1% | 149 | $443.88 | |
| 81003 | <1% | 9,932 | $423.76 | |
| 84439 | <1% | 475 | $420.17 | |
| 85027 | <1% | 3,872 | $415.81 | |
| 0064A | <1% | 12 | $411.00 | |
| 86901 | <1% | 9,908 | $408.82 | |
| 94799 | <1% | 1,296 | $387.45 | |
| 73560 | <1% | 14 | $386.64 | |
| 97165 | <1% | 14 | $376.36 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,231 | $364.29 |
| 86140 | <1% | 1,977 | $301.04 | |
| G0008 | Administration of influenza virus vaccine | <1% | 76 | $293.31 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,442 | $269.01 |
| 85651 | <1% | 1,080 | $266.21 | |
| 84460 | <1% | 1,747 | $265.65 | |
| 80076 | <1% | 12,191 | $234.51 | |
| 93296 | <1% | 12 | $233.71 | |
| 81002 | <1% | 884 | $226.18 | |
| 84450 | <1% | 1,687 | $208.11 | |
| 83615 | <1% | 1,085 | $204.47 | |
| 84100 | <1% | 6,963 | $198.46 | |
| 88307 | <1% | 41 | $187.34 | |
| 29125 | <1% | 402 | $167.00 | |
| 12011 | <1% | 344 | $167.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 616 | $158.64 |
| 82962 | <1% | 86 | $151.58 | |
| 83550 | <1% | 296 | $136.70 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 17,510 | $127.99 |
| 82077 | <1% | 11,021 | $119.33 | |
| 87186 | <1% | 1,848 | $117.19 | |
| 85018 | <1% | 3,392 | $114.35 | |
| 82607 | <1% | 62 | $111.98 | |
| 83540 | <1% | 293 | $111.12 | |
| 85014 | <1% | 3,374 | $109.14 | |
| 87088 | <1% | 2,163 | $107.73 | |
| 84075 | <1% | 478 | $103.38 | |
| 70360 | <1% | 51 | $101.87 | |
| 87040 | <1% | 2,747 | $98.64 | |
| 87070 | <1% | 757 | $95.45 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,584 | $93.51 |
| 87077 | <1% | 1,437 | $75.80 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 2,247 | $72.70 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 8,719 | $69.68 |
| 82150 | <1% | 1,548 | $68.74 | |
| 82553 | <1% | 3,353 | $68.05 | |
| 84145 | <1% | 484 | $67.12 | |
| 94644 | <1% | 280 | $66.58 | |
| 76870 | <1% | 133 | $59.64 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 7,343 | $59.10 |
| 82570 | <1% | 239 | $53.61 | |
| 85379 | <1% | 2,999 | $49.70 | |
| 73552 | <1% | 28 | $48.48 | |
| 73060 | <1% | 38 | $48.14 | |
| 87205 | <1% | 755 | $41.70 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 24,928 | $41.06 |
| 80143 | <1% | 4,110 | $39.93 | |
| 80179 | <1% | 3,917 | $39.93 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 22 | $38.77 |
| 87081 | <1% | 13 | $38.21 | |
| 84550 | <1% | 303 | $33.40 | |
| J3490 | Unclassified drugs | <1% | 11,938 | $27.32 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 6,860 | $25.68 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 31,188 | $25.09 |
| J1643 | Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units | <1% | 202 | $25.05 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,787 | $23.85 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 8,119 | $23.49 |
| 84156 | <1% | 189 | $21.50 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 5,028 | $21.24 |
| 82140 | <1% | 110 | $20.19 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 398 | $19.44 |
| 86592 | <1% | 13 | $19.21 | |
| 87340 | <1% | 12 | $14.28 | |
| J1836 | Injection, metronidazole, 10 mg | <1% | 143 | $12.63 |
| 85652 | <1% | 190 | $12.11 | |
| 86308 | <1% | 311 | $11.85 | |
| 80164 | <1% | 334 | $10.33 | |
| 80177 | <1% | 109 | $7.25 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,469 | $6.76 |
| 84703 | <1% | 72 | $5.70 | |
| 36416 | <1% | 187 | $5.00 | |
| 85347 | <1% | 123 | $4.60 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 3,452 | $4.26 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 895 | $4.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | <1% | 137 | $3.69 |
| 85045 | <1% | 28 | $2.70 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 4,403 | $1.81 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 3,423 | $0.11 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 10,615 | $0.03 |
| J1815 | Injection, insulin, per 5 units | 0% | 2,437 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 8,067 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 1,629 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 1,433 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 1,207 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 1,434 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 727 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 292 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 408 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 5,310 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 609 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 1,526 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 9,297 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 96 | $0.00 |
| 94761 | 0% | 1,121 | $0.00 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 644 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 3,252 | $0.00 |
| 96376 | 0% | 1,844 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 129 | $0.00 |
| 94760 | 0% | 413 | $0.00 | |
| 91301 | 0% | 47 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 89 | $0.00 |
| 96127 | 0% | 103 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 362 | $0.00 |
| 76377 | 0% | 227 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 247 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 223 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 129 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 125 | $0.00 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 52 | $0.00 |
| 88311 | 0% | 24 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 41 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 0% | 12 | $0.00 |
| 64415 | 0% | 13 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 326 | $0.00 |
| 76942 | 0% | 348 | $0.00 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 2,054 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 109 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 4,653 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 1,021 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 904 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 860 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 2,385 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 38 | $0.00 |
| 90461 | 0% | 61 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 297 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 929 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 871 | $0.00 |
| 87075 | 0% | 31 | $0.00 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 881 | $0.00 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 0% | 407 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 203 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 219 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 40 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 256 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 161 | $0.00 |
| J1245 | Injection, dipyridamole, per 10 mg | 0% | 77 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 38 | $0.00 |
| 0042T | 0% | 41 | $0.00 | |
| 80074 | 0% | 38 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 42 | $0.00 |
| 94729 | 0% | 54 | $0.00 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 0% | 28 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 28 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 28 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 23 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 94 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAMSCHRODER, ROBIN (PRESIDENT, VAL BASED ENT &CFO)
| Provider | Location | Paid |
|---|---|---|
| Henry Ford Health System | Detroit, MI | $334.91M |
| Henry Ford Health ST. John Hospital | Chicago, IL | $159.41M |
| Henry Ford Health Providence Hospital | Novi, MI | $72.76M |
| Henry Ford Wyandotte Hospital | Wyandotte, MI | $60.54M |
| W.A. Foote Memorial Hospital | Jackson, MI | $41.32M |
| Henry Ford Macomb Hospital Corporation | Clinton Twp, MI | $40.96M |
| Henry Ford Health Genesys Hospital | Grand Blanc, MI | $31.39M |
| Henry Ford Health Macomb Oakland Hospital | Madison Heights, MI | $24.76M |
| Henry Ford Health System | West Bloomfield, MI | $19.27M |
| Henry Ford Health Rochester Hospital | Rochester, MI | $11.98M |
| Henry Ford Health River District Hospital | East China, MI | $4.59M |
| W.A. Foote Memorial Hospital | Jackson, MI | $2.11M |
| Henry Ford Health Providence Hospital | Novi, MI | $255K |
| Henry Ford Health ST. John Hospital | Detroit, MI | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.